Group 1 - The beauty care sector experienced a significant rise at the beginning of trading, with Jeya Co., Ltd. (301108) increasing by over 10% [1] - Yiyi Co., Ltd. (001206) approached the daily limit increase, indicating strong market interest [1] - Aimeike (300896) saw an increase of over 4%, reflecting positive sentiment in the industry [1] Group 2 - Other companies such as Shuiyang Co., Ltd. (300740) and Shanghai Jahwa United Co., Ltd. (600315) also experienced upward movement, suggesting a broader trend in the beauty care sector [1]

Core Viewpoint - The company is set to implement a restricted stock incentive plan for 2025, which is deemed beneficial for its long-term development and aligns with the interests of shareholders [1][4]. Group 1: Eligibility and Conditions - The company has the necessary qualifications to implement the incentive plan, ensuring that the incentive objects meet the legal and regulatory requirements [2]. - Specific prohibitive conditions for implementing the stock incentive plan include negative audit opinions on financial reports and failure to distribute profits according to legal and regulatory standards [1][2]. Group 2: Incentive Objects - The incentive plan targets directors, senior management, core technical and business personnel, and other employees who directly impact the company's performance, excluding foreign personnel and major shareholders [2][3]. Group 3: Disclosure and Approval Process - The company must publicly disclose the names and positions of the incentive objects for at least 10 days before the shareholders' meeting, allowing for feedback on the proposed list [3]. - The plan requires approval from the shareholders' meeting before implementation, ensuring compliance with relevant laws and regulations [3][4]. Group 4: Strategic Alignment - The incentive plan is designed to create a shared interest between employees and shareholders, enhancing management efficiency and supporting the company's sustainable development [4].

Group 1 - The company held its sixth board meeting on July 21, 2025, via communication, with 9 directors expected to attend and all legal requirements met [1] - The board approved the draft of the 2025 Restricted Stock Incentive Plan to attract and retain talent, enhance the incentive effect, and promote long-term stable development [1][2] - The plan requires approval from the shareholders' meeting, needing more than two-thirds of the voting rights to pass [2][6] Group 2 - The board proposed to authorize the board to manage the implementation of the 2025 Restricted Stock Incentive Plan, including determining eligibility and adjusting stock grants based on corporate actions [4][5] - The board's decision on the incentive plan received 3 votes in favor and 1 against, with the dissenting director citing concerns over the timing and conservativeness of the plan [2][6][8] - The company plans to hold a temporary shareholders' meeting on August 8, 2025, to discuss the incentive plan and other matters [7]

Meeting Information - The company will hold its fourth extraordinary general meeting of shareholders on August 8, 2025, at 14:30 [1] - Network voting will also take place on the same day, with specific time slots for voting through the Shenzhen Stock Exchange trading system and internet voting system [1][2] Voting Procedures - Shareholders can choose to attend the meeting in person or authorize a representative to attend [2] - Network voting is available through the Shenzhen Stock Exchange trading system and internet voting system, with detailed procedures provided [5][7] Agenda Items - The meeting will review several proposals, including the draft of the 2025 Restricted Stock Incentive Plan and related matters [3][4] - Proposals 1 to 3 require a special resolution, needing more than two-thirds of the votes from attending shareholders [4] Registration and Attendance - The record date for shareholders to attend the meeting is August 4, 2025, and those holding shares on this date are eligible to participate [4] - Specific registration procedures are outlined for both individual shareholders and authorized representatives [4][6] Additional Information - The company will separately count votes from minority investors, defined as shareholders excluding directors, senior management, and those holding more than 5% of shares [4] - The company has provided a detailed voting process for shareholders participating via the internet [5][7]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-054 铜陵洁雅生物科技股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 铜陵洁雅生物科技股份有限公司（以下简称"公司"或"洁雅股份"）于 2025 年 7 月 21 日召开第六届董事会第二次会议，审议通过了《关于为参股公司提供担 保暨关联交易的议案》。本事项已经公司独立董事专门会议审议通过。 根据业务发展需要，公司参股公司赛得利（铜陵）无纺材料有限公司（以下 简称"赛得利铜陵"）拟向银行申请总额度为 3000 万元的贷款，贷款期限为三年。 公司及其他各方股东拟按各自持股比例提供担保，公司持有赛得利铜陵 20%的股 权，赛得利（九江）纤维有限公司（以下简称"赛得利九江"）持有赛得利铜陵 式为连带责任担保，担保期限以与银行签署的协议为准，其余股东按照持股比例 为赛得利铜陵提供担保。 公司董事长兼总经理蔡英传先生在赛得利铜陵担任董事，公司董事兼财务总 监杨凡龙先生在赛得利铜陵担任监事。根据《深圳证券交易所创业板股票上市规 则》的规定，赛得利铜陵为公司的关联法人。本次公司与 ...

Core Viewpoint - The legal opinion letter from Anhui Tianhe Law Firm confirms that Tongling Jieya Biotechnology Co., Ltd. is eligible to implement its 2025 restricted stock incentive plan, adhering to relevant laws and regulations [1][3][29]. Group 1: Company Background - Tongling Jieya Biotechnology Co., Ltd. is a legally established and validly existing listed company, having been registered in December 2008 and listed on the Shenzhen Stock Exchange's Growth Enterprise Market [3][4]. - The company holds a business license issued by the Market Supervision Administration of Tongling City, with a unified social credit code [4]. Group 2: Incentive Plan Overview - The purpose of the 2025 restricted stock incentive plan is to establish a long-term incentive mechanism to attract and retain talent, aligning the interests of shareholders, the company, and core team members [5][10]. - The plan involves granting a total of 1.82 million restricted shares, accounting for 1.62% of the company's total share capital as of the announcement date [9][10]. Group 3: Eligibility and Conditions - The incentive plan specifies that eligible participants include directors, senior management, and other personnel deemed necessary for motivation, excluding independent directors and certain major shareholders [6][8]. - The plan outlines specific conditions under which restricted shares can be granted and vested, including performance targets based on revenue growth rates for the years 2025 to 2027 [18][19]. Group 4: Granting and Vesting Details - The initial grant price for the restricted shares is set at 12.63 yuan per share, which is compliant with the stipulated pricing regulations [15][29]. - The vesting schedule includes multiple phases, with specific percentages of shares vesting after designated periods, contingent upon meeting performance criteria [12][19]. Group 5: Adjustments and Procedures - The plan includes provisions for adjustments to the number and price of restricted shares in the event of corporate actions such as stock splits or capital increases [20][22]. - The implementation of the incentive plan requires approval from the board of directors and the shareholders' meeting, with specific procedures for public disclosure and compliance with legal requirements [23][24].

Summary of Key Points from the Conference Call of Jieya Co., Ltd. Company Overview - Jieya Co., Ltd. is benefiting from Kimberly-Clark's strategic adjustments in the European market, with expected new orders in 2025 bringing nearly 200 million RMB in sales [2][6] - The company is actively expanding its business in Australia, New Zealand, Southeast Asia, and Latin America, indicating significant growth in international markets [2] Core Business Developments - Jieya has secured a project with Procter & Gamble in the Canadian market, with an expected annual sales of approximately 30 million RMB, potentially increasing to nearly 100 million RMB [2][8] - The new factory in North Carolina, USA, originally planned to start production in 2025, has been delayed to Q1 2026 due to approval and client review factors, with a designed capacity of 100 million USD [2][11] - In the first half of 2025, Jieya's revenue growth is expected to be around 10%, with better profit growth anticipated, and a faster growth rate expected in the second half of the year [2][15] Client and Market Structure - Jieya primarily serves major international brands such as Johnson & Johnson, Kimberly-Clark, Procter & Gamble, L'Oréal, and Australia's largest supermarket chain, Woolworths [4] - The company's business structure is heavily focused on wet wipes, which constitute the majority of its offerings, while cosmetics account for about 10% of overall business [4] Financial Performance and Projections - In Q1 2025, Jieya reported a slight decline in performance, but a recovery is expected in Q2 due to new orders, with overall performance showing improvement [3][15] - The company has a strong financial reserve of approximately 1.3 billion RMB, sufficient to support business expansion [5][30] Strategic Partnerships and Market Trends - The strategic shift by Kimberly-Clark to outsource production has created opportunities for Jieya, with a significant increase in orders expected [7] - The wet wipes industry is facing increased competition from new entrants, but major players like Jieya focus on their market shares without significant conflict [17] Future Growth and Investment Plans - Jieya aims to explore international market opportunities and product categories as key growth drivers, with plans to maintain stable growth in core business areas [13][14] - The company is considering investments and acquisitions to seek business growth, particularly targeting brand collaborations [24] Challenges and Risks - The company faces challenges in the cosmetics sector due to reduced orders from L'Oréal, but it plans to continue serving L'Oréal while expanding domestic client relationships [5][23] - There are uncertainties regarding the production timeline of the new factory in the USA, which could impact future revenue [11][20] Export and Domestic Sales Dynamics - Jieya's export ratio is expected to increase from 50% in 2024 to 70% in 2025, while domestic sales are projected to decrease to 30% [27] Profitability Outlook - The gross margin is projected to improve as international business grows, with current margins around 20%-25% for international operations and about 10% for domestic [28] Conclusion - Jieya Co., Ltd. is positioned for growth through strategic partnerships, international market expansion, and a focus on core competencies in wet wipes, while navigating challenges in the cosmetics sector and maintaining a strong financial foundation [31]

Group 1: Company Overview - Tongling Jeya Biotechnology Co., Ltd. specializes in the research, production, and sales of wet wipes, with over 20 years of industry experience [1][2] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021 [2] Group 2: Financial Performance - In the first quarter of 2025, the company reported a revenue of 124 million yuan and a net profit of 1,006.27 million yuan [3] Group 3: Key Clients and Market Expansion - Major clients for the wet wipes business include international brands such as Woolworths, Kimberly-Clark, Johnson & Johnson, and Procter & Gamble, as well as domestic e-commerce brands like babycare and Dongfang Zhenxuan [3] - The company has seen a stable order flow from existing clients and has successfully secured new business in Europe and Canada [3] Group 4: U.S. Factory Development - The company acquired a wet wipes factory in the U.S. this year, currently undergoing renovations and equipment installation, with production expected to start in Q1 2026 [3] - Risks associated with the U.S. factory include uncertainties in renovation and approval processes, client audits, potential delays in production, and cultural differences affecting efficiency [3] Group 5: Brand Development and Other Ventures - The company's efforts to develop its own brand through fund incubation have not met expectations, leading to a significant reduction in investment [3] - The joint venture with Jiangsu Chuangjian for collagen products has not made substantial progress due to rapid market changes [3] Group 6: Compliance and Regulations - The investor communication activity adhered to the Shenzhen Stock Exchange's self-regulatory guidelines, ensuring no significant undisclosed information was leaked [4]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-054 关于为参股公司提供担保暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 铜陵洁雅生物科技股份有限公司（以下简称"公司"或"洁雅股份"）于 2025 年 7 月 21 日召开第六届董事会第二次会议，审议通过了《关于为参股公司提供担 保暨关联交易的议案》。本事项已经公司独立董事专门会议审议通过。 根据业务发展需要，公司参股公司赛得利（铜陵）无纺材料有限公司（以下 简称"赛得利铜陵"）拟向银行申请总额度为 3000 万元的贷款，贷款期限为三年。 公司及其他各方股东拟按各自持股比例提供担保，公司持有赛得利铜陵 20%的股 权，赛得利（九江）纤维有限公司（以下简称"赛得利九江"）持有赛得利铜陵 80%的股权。公司拟按持股比例为赛得利铜陵提供 600 万元的最高额担保，担保方 式为连带责任担保，担保期限以与银行签署的协议为准，其余股东按照持股比例 为赛得利铜陵提供担保。 公司董事长兼总经理蔡英传先生在赛得利铜陵担任董事，公司董事兼财务总 监杨凡龙先生在赛得利铜陵担任监 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-055 铜陵洁雅生物科技股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第六届董事会第二次 会议审议通过了《关于召开 2025 年第四次临时股东会的议案》，决定于 2025 年 8 月 8 日（星期五）召开公司 2025 年第四次临时股东会，现将本次股东会的 有关事项通知如下： 一、召开会议的基本情况 1. 股东会届次：2025 年第四次临时股东会。 2. 股东会的召集人：公司董事会。 3. 会议召开的合法、合规性：本次股东会的召集和召开符合有关法律、行 政法规、部门规章、规范性文件及《公司章程》的规定和要求。 4. 会议召开的日期、时间： （1）现场会议召开时间：2025 年 8 月 8 日（星期五）14:30。 （2）网络投票时间：2025 年 8 月 8 日（星期五）。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 8 月 8 日 9:15-9:25，9:30 ...